AI Terminal
Pharmanutra
Governance Information • Mar 23, 2025
4324_agm-r_2025-03-23_15894dcf-650d-4442-885d-267df2db3e97.pdf
Governance Information
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 20106-10-2025 |
Data/Ora Inizio Diffusione 23 Marzo 2025 07:20:13 |
Euronext Star Milan | |
|---|---|---|---|
| Societa' | : | PHARMANUTRA | |
| Identificativo Informazione Regolamentata |
: | 202784 | |
| Utenza - Referente | : | PHARMANUTRAN04 - Roberto Lacorte | |
| Tipologia | : | REGEM; 3.1 | |
| Data/Ora Ricezione | : | 23 Marzo 2025 07:20:13 | |
| Data/Ora Inizio Diffusione | : | 23 Marzo 2025 07:20:13 | |
| Oggetto | : | NOTICE OF FILING OF THE LIST FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDITORS |
|
| Testo del comunicato |
Vedi allegato
PHARMANUTRA S.P.A.: NOTICE PURSUANT TO ARTICLE 144-OCTIES, PARAGRAPH 2, OF CONSOB REGULATION NO. 11971/1999
NOTICE OF FILING OF THE LIST FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDITORS REOPENING OF THE DEADLINES FOR THE SUBMISSION OF THE LIST FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDITORS
Pisa, March 23, 2025 – With reference to the Shareholders' Meeting of Pharmanutra S.p.A. convened for April 16, 2025, at 11:00 AM, it is hereby announced that, as of March 22, 2025 (the deadline for the submission of lists), only one list of candidates for the appointment of the members of the Board of Statutory Auditors has been submitted by the shareholder ALH S.r.l., holder of 3,038,334 shares, equal to 31.384% of the subscribed and paid-up share capital of Pharmanutra S.p.A.
Pursuant to Article 144-sexies, paragraph 5, of Consob Regulation No. 11971/1999, it is also announced that, since only the aforementioned list has been submitted as of March 22, 2025, for the appointment of the members of the Board of Statutory Auditors, additional lists (accompanied by the documentation required by applicable provisions, including statutory ones) may be submitted by minority shareholders for the appointment of the members of the Board of Statutory Auditors no later than Wednesday, March 25, 2025 (in the manner and within the terms specified in the notice of the meeting). The threshold required for the submission of such lists is reduced by half, to 1.25% of the share capital of Pharmanutra S.p.A.
The lists, accompanied by the documentation required by current legal and regulatory provisions, will be made available to the public by March 26, 2025, at the company's registered office at Via Campodavela, 1, Pisa (PI), through the eMarket Storage mechanism at , and on the company's website (www.pharmanutra.it, in the Governance/Shareholders' Meeting section).
PharmaNutra S.p.A.
PharmaNutra S.p.A.
Founded and led by President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra is a company founded in 2003 that develops unique nutritional supplements and innovative medical devices, taking care of the entire production process. PharmaNutra is a leader in the production of iron-based nutritional supplements under the SiderAL® brand, where it boasts important patents on Sucrosomial® Technology, and is considered one of the top emerging players in the field of medical devices dedicated to the restoration of joint capacity thanks to the Cetilar® brand , now also on the market in the Nutrition version, a line of supplements designed for those who practice sports constantly. Over the years, the Group – present abroad in over 80 countries – has developed a precise strategy in the production of intellectual property, based on the integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence. PharmaNutra.it.
For more information:
Via Campodavela 1 - 56122 Pisa
Tel. +39 050 7846500
Internal Press Office
PharmaNutra S.p.A. Press Office - Spriano Communication & Partners
Via Santa Radegonda, 16 - 20121 Milan
Tel. +39 02 83635708
Matteo Russo [email protected] Cristina Tronconi
Registered Office Via Campodavela, 1 - 56122 Pisa | +39 050 7846500 pharmanutra.it | [email protected] | [email protected] C.F. / P.Iva / Reg. Impr. 01679440501 - SDI Code SUBM70N Cap.Soc. € 1.123.097,70 I.V. | REA 146259
| Fine Comunicato n.20106-10-2025 | Numero di Pagine: 4 |
|---|---|
| --------------------------------- | --------------------- |